Arkadios Wealth Advisors grew its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 122.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,378 shares of the company's stock after buying an additional 7,902 shares during the period. Arkadios Wealth Advisors' holdings in Colgate-Palmolive were worth $1,347,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Bayforest Capital Ltd boosted its holdings in shares of Colgate-Palmolive by 259.4% in the 1st quarter. Bayforest Capital Ltd now owns 3,386 shares of the company's stock valued at $317,000 after buying an additional 2,444 shares during the period. Vestcor Inc boosted its stake in Colgate-Palmolive by 2.5% in the first quarter. Vestcor Inc now owns 299,420 shares of the company's stock valued at $28,056,000 after acquiring an additional 7,353 shares during the period. XTX Topco Ltd bought a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $606,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $676,000. Finally, Banque Cantonale Vaudoise bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $4,428,000. 80.41% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
CL has been the subject of a number of analyst reports. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating for the company in a report on Friday, July 25th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Citigroup lifted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Finally, Barclays upped their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Hold" and an average target price of $100.58.
View Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Price Performance
NYSE:CL traded down $0.34 during midday trading on Friday, hitting $83.51. 9,606,667 shares of the stock were exchanged, compared to its average volume of 4,901,203. The company has a market capitalization of $67.68 billion, a price-to-earnings ratio of 23.46, a P/E/G ratio of 4.31 and a beta of 0.35. The company has a current ratio of 0.43, a quick ratio of 0.28 and a debt-to-equity ratio of 8.96. Colgate-Palmolive Company has a one year low of $82.70 and a one year high of $109.30. The business has a 50-day moving average price of $89.59 and a two-hundred day moving average price of $90.31.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 EPS. Sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is 58.76%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.